Category: Approval/Launch Region: North America · United States Company: Insightec Ltd

Insightec Receives Fda Ide Approval And Breakthrough Designation For Nsclc Brain Mets Study And Ide Approval For Liquid Biopsy Study

Insightec Receives Fda Ide Approval And Breakthrough Designation For Nsclc Brain Mets Study And Ide Approval For Liquid Biopsy Study
Designation and approvals mark key milestones in advancing Insightec Blood Brain Barrier (BBB) clinical roadmap using Acoustic Therapy Insightec, a global healthcare company dedicated to using acoustic energy to transform patient care, today announced that it has received FDA approval of two pivotal investigational device exemptions (IDE) for its Exablate Neuro system

Found this useful? Share it with your team.

Welcome Back Sign in to Continue

Don't Have an Account? Sign Up!
Forgot Password?

Create your Account!

Don't Have an Account? Sign Up!